Dry Needling Versus Ozone in Myofascial Pain Syndrome

Launched by USKUDAR STATE HOSPITAL · Aug 8, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different treatments for people who have myofascial pain syndrome, which often causes pain in the upper trapezius area, commonly known as tension in the neck and shoulder. The trial will compare dry needling (a method that involves inserting thin needles into the muscle) and ozone therapy (which uses a gas to help reduce pain) to see which one is more effective in relieving pain and improving daily activities.

To participate in this study, you need to be an adult between 18 and 65 years old with a diagnosis of myofascial pain syndrome affecting your upper trapezius area. You should be healthy enough to take part, and you should not have had either dry needling or ozone therapy before. Participants will undergo assessments to track their pain and functionality, and they will be asked to commit to the study for a specific duration. It’s important to note that if you have certain health conditions, like severe heart issues or infections, or if you are pregnant or breastfeeding, you may not be eligible to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults (18-65 years) with diagnosed myofascial pain syndrome affecting the upper trapezius area Willing and able to provide informed consent Able to comprehend and complete study-related assessments Diagnosed with myofascial pain syndrome affecting the upper trapezius area, based on clinical assessment and Simons and Travell criteria No prior exposure to dry needling or ozone therapy for myofascial pain syndrome Medically stable and cleared by a physician for study participation No active musculoskeletal injuries or conditions in the upper trapezius area No participation in similar interventions within the last 6 months
• Exclusion Criteria:
• • Individuals with known contraindications to dry needling or ozone therapy Severe cardiovascular conditions or uncontrolled hypertension Active infections or skin conditions at treatment sites Known bleeding disorders or anticoagulant use Diagnosed with any other chronic pain syndrome not related to myofascial pain syndrome Any ongoing litigation or compensation claims related to pain conditions Recent trauma or surgery in the upper trapezius area Previous adverse reactions to dry needling or ozone therapy Participation in other investigational studies within the last 3 months History of psychological conditions that might interfere with assessment Pregnant or breastfeeding History of malignancy or immunocompromised status Neurological disorders affecting upper trapezius function Severe cognitive impairments that hinder assessment Inability to commit to the study duration or follow-up assessments Any change in medication regimen that might impact pain or functionality during the study period